Glipizide
Administration
- Type: Sulfonylurea
- Dosage Forms:
- Routes of Administration:
- Common Trade Names: Glucotrol
Adult Dosing
- 5-10mg PO daily
Pediatric Dosing
Safety/efficacy not established
Special Populations
Pregnancy Rating
- Category C
Lactation risk
- Excretion minimal, likely safe
Renal Dosing
- Not studied
Hepatic Dosing
- 2.5mg daily
Contraindications
- Allergy to class/drug (including sulfa allergy)
- Type 1 diabetes
- Diabetic ketoacidosis
- Caution if risk of severe hypoglycemia (elderly, debilitated, malnourished, adrenal/pituitary insufficiency, physiologic stressors)
- Concomitant use of beta blockers or other sympatholytics (may impair ability to recognize symptoms of hypoglycemia)
Adverse Reactions
Serious
- Hypoglycemia
- Cholestatic jaundice, hepatitis, liver failure
- See sulfonylurea toxicity
Common
- Hypoglycemia
- Rash, skin eruptions
- Abdominal pain, diarrhea, constipation, flatulence, heartburn, nausea/vomiting
- Syncope
- Headache, dizziness, anxiety, depression, drowsiness
Pharmacology
- Half-life: 2-5h
- Metabolism: Hepatic
- Excretion: Urinary
Mechanism of Action
- Increases insulin secretion from pancreatic beta cells. May decrease rate of hepatic glucose production and increase insulin receptor sensitivity
Comments
See Also
References
This article is issued from
Wikem.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.